NVIDIA and Eli Lilly have unveiled a landmark $1 billion partnership to launch a first-of-its-kind AI co-innovation lab in the San Francisco Bay Area. By co-locating world-class scientists and AI engineers, the collaboration aims to “industrialize” drug discovery through advanced foundation models, robotics, and “lab-in-a-loop” workflows.
The Food and Drug Administration’s approval of lecanemab, a new Alzheimer’s medication shown in clinical trials to reduce the disease slowly over time.
A study team headed by Gernot Längst (University of Regensburg) and Markus Meißner (LMU Munich) has made significant progress in understanding the gene regulation of the malaria pathogen.
Although AI and quantum computing have simplified the process of designing tiny molecules for medicinal therapy, this has resulted in the need for far quicker techniques to verify the effectiveness of novel medications.
A new compound created by researchers at Washington University School of Medicine in St. Louis successfully cures bacterial infections in mice, including those that can cause [Read More…]
Researchers at UC San Francisco have created a medication that might potentially provide a cure for pancreatic cancer, an almost always fatal illness.
A drug that attaches itself to antibodies that cause allergies can save kids from harmful responses when they unintentionally consume foods that cause allergies.
